基本信息
views: 352
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
In 2016, Hwang was chosen to lead the first United States based study on how to manage pre-cancers of the breast titled Comparison of Operative to Medical Endocrine Therapy. The study focused on whether treatments for ductal carcinoma in situ were necessary or helpful in reducing the spread of the canercous tumours. Her focus on treatments for ductal carcinoma in situ reflect a conservative approach as she feels women are too often quick to choose mastectomies and suffer emotionally and physically afterwards.
Research Interests
Papers共 566 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International Journal of Molecular Sciencesno. 12 (2024): 6748
Daniela P. Ladner, Allan M. Goldstein,Timothy R. Billiar,Andrew M. Cameron,Darren R. Carpizo,Daniel I. Chu,Craig M. Coopersmith, Ronald P. Dematteo,Sandy Feng,Katherine A. Gallagher, William E. Gillanders,Brajesh K. Lal,
Sena Alaeikhanehshir,Madelon M. Voets,Frederieke H. van Duijnhoven, Esther H. Lips,Emma J. Groen,Marja C. J. van Oirsouw,Shelley E. Hwang,Joseph Y. Lo, Jelle Wesseling,Ritse M. Mann,Jonas Teuwen
Cancer imaging : the official publication of the International Cancer Imaging Societyno. 1 (2024): 48-48
Breast Cancer Researchno. 1 (2024): 1-14
Cancer Researchno. 9_Supplement (2024): PO4-13
JOURNAL OF CLINICAL MEDICINEno. 7 (2024): 1937
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 14 (2024): 1635-1645
Load More
Author Statistics
#Papers: 553
#Citation: 18602
H-Index: 67
G-Index: 129
Sociability: 8
Diversity: 3
Activity: 344
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn